focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,774.50
Ask: 1,775.50
Change: 0.00 (0.00%)
Spread: 1.00 (0.056%)
Open: 1,775.50
High: 1,778.50
Low: 1,769.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Barclays Downgrades Zoopla To Equal Weight

Thu, 21st Apr 2016 08:31

LONDON (Alliance News) - The following shares received analyst recommendations Thursday morning and Wednesday:
----------
FTSE 100
----------
JEFFERIES RAISES LAND SECURITIES PRICE TARGET TO 975 (957) PENCE - 'HOLD'
----------
JEFFERIES CUTS INTU PROPERTIES PRICE TARGET TO 240 (247) PENCE - 'UNDERPERFORM'
----------
JEFFERIES CUTS HAMMERSON PRICE TARGET TO 473 (493) PENCE - 'UNDERPERFORM'
----------
JEFFERIES CUTS BRITISH LAND PRICE TARGET TO 570 (615) PENCE - 'UNDERPERFORM'
----------
EXANE BNP RAISES GLAXOSMITHKLINE PRICE TARGET TO 1430 (1350) PENCE - 'NEUTRAL'
----------
MORGAN STANLEY RAISES GLAXOSMITHKLINE PRICE TARGET TO 1500 (1450) PENCE - 'EQUALWEIGHT'
----------
CITIGROUP RAISES ARM HOLDINGS PRICE TARGET TO 1060 (1045) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES BHP BILLITON PRICE TARGET TO 780 (665) PENCE - 'UNDERWEIGHT'
----------
HSBC RAISES SHELL PRICE TARGET TO 2000 (1925) PENCE - 'BUY'
----------
HSBC RAISES BP PRICE TARGET TO 410 (405) PENCE - 'BUY'
----------
GOLDMAN RAISES BUNZL PRICE TARGET TO 1800 (1780) PENCE - 'SELL'
----------
GOLDMAN RAISES RECKITT BENCKISER PRICE TARGET TO 6680 (6640) PENCE - 'NEUTRAL'
----------
BERENBERG RAISES WOLSELEY PRICE TARGET TO 4400 (4300) PENCE - 'BUY'
----------
CHARLES STANLEY RAISES AB FOODS TO 'HOLD' ('REDUCE')
----------
MORGAN STANLEY RAISES SAGE GROUP PRICE TARGET TO 470 (440)P - 'UNDERWEIGHT'
----------
FTSE 250
----------
BARCLAYS CUTS ZOOPLA TO 'EQUAL WEIGHT' ('OVERWEIGHT') - TARGET 295 (270) PENCE
----------
PANMURE CUTS AVEVA GROUP PRICE TARGET TO 1864 (1910) PENCE - 'HOLD'
----------
MORGAN STANLEY RAISES AVEVA GROUP TARGET TO 1,240 (1,150)P - 'UNDERWEIGHT'
----------
JEFFERIES CUTS WORKSPACE GROUP PRICE TARGET TO 765 (804) PENCE - 'HOLD'
----------
JEFFERIES RAISES UNITE GROUP PRICE TARGET TO 575 (569) PENCE - 'HOLD'
----------
JEFFERIES RAISES SHAFTESBURY PRICE TARGET TO 888 (801) PENCE - 'HOLD'
----------
JEFFERIES CUTS SEGRO PRICE TARGET TO 380 (414) PENCE - 'HOLD'
----------
JEFFERIES RAISES LONDONMETRIC PROPERTY PRICE TARGET TO 165 (153) PENCE - 'HOLD'
----------
JEFFERIES CUTS HANSTEEN PRICE TARGET TO 110 (115) PENCE - 'HOLD'
----------
JEFFERIES CUTS GREAT PORTLAND PRICE TARGET TO 668 (705) PENCE - 'HOLD'
----------
JEFFERIES CUTS GRAINGER PRICE TARGET TO 215 (240) PENCE - 'HOLD'
----------
JEFFERIES CUTS DERWENT LONDON PRICE TARGET TO 2950 (3055) PENCE - 'HOLD'
----------
JEFFERIES RAISES BIG YELLOW GROUP PRICE TARGET TO 725 (654) PENCE - 'HOLD'
----------
JEFFERIES CUTS PETROFAC TO 'HOLD' ('BUY')
----------
CREDIT SUISSE RAISES SERCO GROUP PRICE TARGET TO 100 (95) PENCE - 'NEUTRAL'
----------
BERENBERG CUTS VICTREX TO 'HOLD' ('BUY') - TARGET 1620 (1800) PENCE
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.